3rd Quarter - Report

MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY

Firm
Client
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion. H.R.4709 "Ensuring Patient Access and Effective Drug Enforcement Act of 2014" S.2862 "Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014"

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —
JOSEPH M GANLEY New —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4709 (113th), S. 2862 (113th)

Taxation/Internal Revenue Code TAX

Proposals to repeal LIFO

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —
JOSEPH M GANLEY New —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Incentives for health information technology, Affordable Care Act implementation, and other healthcare policy issues. Proposed regulation of medical software. H.R. 3303 "SOFTWARE Act of 2013". S. 2007 "PROTECT Act of 2014".

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —
JOSEPH M GANLEY New —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2007 (113th), H.R. 3303 (113th)

Veterans VET

Existing Department of Veterans' Affairs Pharmaceutical Prime Vendor contract.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —
JOSEPH M GANLEY New —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Medicare/Medicaid MMM

Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013" H R 4302 "Protecting Access to Medicare Act of 2014" (PL 113-93) H.R. 1416 "Cancer Patient Protection Act of 2013"S.806/H.R.800 "To amend Part B of title XVII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biological under Medicare"

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —
MATT BROW —
JOSEPH M GANLEY New —
KEAGAN R LENIHAN —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 800 (113th), H.R. 2869 (113th), H.R. 1416 (113th), H.R. 4302 (113th), S. 806 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.